Health
New initiative identifies key parameters underlying effective anti-tumor immunity – News-Medical.Net
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies.
Reviewed by Emily Henderson, B.Sc.Oct 9 2020
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies. Targeting the “right” neoantigens – in a cancer vaccine or a cell therapy – has the promise to eliminate a patient’s cancer with minimal side effects. But hundreds of mutations can exist in a tumor, and only some can give rise to neoantigens that can trigger an immune response against cancer. The q…
-
Business19 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News19 hours agoYoung voices shape Sunshine Coast’s future
-
General23 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’
-
General23 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate